Joseph K. Belanoff
2011
In 2011, Joseph K. Belanoff earned a total compensation of $3.5M as Chief Executive Officer and President at Corcept Therapeutics.
Compensation breakdown
| Option Awards | $3,057,026 |
|---|---|
| Salary | $467,084 |
| Total | $3,524,110 |
Belanoff received $3.1M in option awards, accounting for 87% of the total pay in 2011.
Belanoff also received $467.1K in salary.
Rankings
In 2011, Joseph K. Belanoff's compensation ranked 1,721st out of 10,747 executives tracked by ExecPay. In other words, Belanoff earned more than 84.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,721 out of 10,747 | 84th |
Division Manufacturing | 625 out of 3,960 | 84th |
Major group Chemicals And Allied Products | 137 out of 1,033 | 87th |
Industry group Drugs | 76 out of 781 | 90th |
Industry Pharmaceutical Preparations | 64 out of 571 | 89th |
Source: SEC filing on April 7, 2014.
Belanoff's colleagues
We found four more compensation records of executives who worked with Joseph K. Belanoff at Corcept Therapeutics in 2011.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019